Russell, Jacquelyn O. http://orcid.org/0000-0001-9928-2869
Camargo, Fernando D. http://orcid.org/0000-0002-5630-5909
Article History
Accepted: 14 December 2021
First Online: 21 January 2022
Competing interests
: F.D.C. holds equity interests and is on the scientific advisory board of Fog Therapeutics. F.D.C. has applied for patents related to inhibition of YAP/TEAD function.